Small company mergers--good for whom?
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 17093475.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An analysis of 105 mergers among small UK biotech companies over a 10-year period shows that the improvement of shareholder positions, rather than product pipelines or business opportunities, is the main motivation for such transactions.
Medical subject headings
- Biotechnology
- Health Care Sector
- Investments